VolitionRX Confirms Dr. Michel’s Leadership and Compensation Plan
Company Announcements

VolitionRX Confirms Dr. Michel’s Leadership and Compensation Plan

VolitionRX ( (VNRX) ) has shared an announcement.

Belgian Volition SRL has renewed its commitment to Dr. Gaetan Michel as CEO with a new employment agreement that includes a monthly wage, bonuses, and a severance package in line with Belgian Law. Concurrently, Volition Global Services has amended its consulting agreement with 3F Management to continue leveraging Dr. Michel’s expertise, providing a monthly fee and performance-related bonuses. These new arrangements secure Dr. Michel’s leadership roles across various subsidiaries and ensure his compensation remains in line with previous figures, underlining the company’s strategic continuity and leadership stability.

For a thorough assessment of VNRX stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskVolitionRx Posts Strong Q3 Growth and Strategic Advances
TheFlyVolitionRx reports Q3 revenue up 187% year-over-year to $475K
Carrie WilliamsIs VNRX a Buy, Before Earnings?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App